Review of immunoprophylaxis for pyoderma and otitis in dogs notes bacterial antigenic diversity limits efficacy

Photo by Rebecca Campbell / Unsplash

Frontiers in Medicine Published May 19, 2026 Medically reviewed May 19, 2026 DOI ↗ By Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease

Key Takeaway

Note that bacterial antigenic diversity limits effective immunoprophylaxis for pyoderma and otitis in dogs.

This publication is a narrative review focusing on immunoprophylaxis strategies for pyoderma, otitis, and postoperative infections in dogs. The scope of the article addresses the challenges associated with developing effective prophylactic measures for these common conditions in veterinary medicine. No specific sample size, intervention details, or comparator groups are reported in the source text. Consequently, quantitative data such as effect sizes or adverse event rates are not available for synthesis.

The authors synthesize the argument that achieving effective immunoprophylaxis is difficult due to bacterial antigenic diversity. This biological complexity is identified as a primary limitation preventing the widespread success of current immunoprophylactic approaches. The review does not provide specific numerical outcomes or detailed safety profiles for the discussed conditions.

Gaps in the literature are highlighted by the absence of reported data on sample sizes, settings, and specific interventions. The authors acknowledge that effective immunoprophylaxis remains elusive because of bacterial antigenic diversity. Practice relevance is constrained by these significant limitations, suggesting that clinicians should interpret current immunoprophylaxis options with caution until more robust evidence emerges.

Study Details

Study typeSystematic review

EvidenceLevel 1

PublishedMay 2026

View Original Abstract ↓

Staphylococcus pseudintermedius is a common commensal bacterium of dogs. It becomes an opportunistic pathogen when it evades the immune and exogenous antimicrobial control to cause pyoderma, otitis, and postoperative infections in dogs. The shift from colonization to invasive disease illustrates an interplay between bacterial virulence and host immune defense. S. pseudintermedius encodes adhesins, exoenzymes, and cytotoxins that facilitate attachment to epithelial surfaces, biofilm formation, and tissue invasion. The bacterium evades the host immune system through IgG-binding proteins, complement inhibition, NET degradation, and modulation of cytokine signaling therefore enabling persistent infection or recurrence, particularly in atopic or immunocompromised hosts. Given that mobile elements found in the genome of S. pseudintermedius may encode resistance and virulence genes, these factors may influence selection for lineages that are virulent and methicillin resistant. The animal host defends itself against S. pseudintermedius by keratinocyte inflammasome activation, neutrophil recruitment, and Th1/Th17 responses. Although these mechanisms drive bacterial clearance, they can cause tissue injury because of inflammation. Despite increased understanding of S. pseudintermedius pathogenesis, effective immunoprophylaxis remains elusive because of bacterial antigenic diversity. Recent research has identified conserved surface proteins and secreted toxins which can serve as candidate antigens for robust vaccine design. This review synthesizes current knowledge on S. pseudintermedius-host interactions, highlighting mechanisms of bacterial defense and evasion. Furthermore, we suggest gaps that warrant further research and outline strategies for immunotherapeutics and vaccines against canine staphylococcal infections.